Cumberland Drug Patent Portfolio
Cumberland owns 4 orange book drugs protected by 13 US patents Given below is the list of Cumberland's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7531623 | Hydrochloride salts of a glycopeptide phosphonate derivative | 01 Jan, 2027 | Active |
| US7608282 | Transdermal granisetron | 22 Jan, 2025 | Active |
| US6635618 | Glycopeptide phosphonate derivatives | 11 Sep, 2023 | Expired |
| US6858584 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin | 24 Aug, 2022 | Expired |
| US6872701 | Glycopeptide phosphonate derivatives | 05 Jun, 2021 | Expired |
| US7008923 | Glycopeptide phosphonate derivatives | 06 May, 2021 | Expired |
| US7208471 | Glycopeptide phosphonate derivatives | 01 May, 2021 | Expired |
| US7351691 | Glycopeptide phosphonate derivatives | 01 May, 2021 | Expired |
| US7544364 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin | 01 May, 2021 | Expired |
| US7700550 | Glycopeptide phosphonate derivatives | 01 May, 2021 | Expired |
| US8101575 | Glycopeptide phosphonate derivatives | 01 May, 2021 | Expired |
| US8158580 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin | 01 May, 2021 | Expired |
| US5723606 | Condensed benzazepine derivative and pharmaceutical composition thereof | 15 Dec, 2019 | Expired |
Latest Legal Activities on Cumberland's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cumberland.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 20 May, 2024 | US8158580 |
|
Expire Patent
Critical
| 26 Feb, 2024 | US8101575 |
|
Maintenance Fee Reminder Mailed
Critical
| 04 Dec, 2023 | US8158580 |
|
Maintenance Fee Reminder Mailed
Critical
| 11 Sep, 2023 | US8101575 |
|
Expire Patent
Critical
| 23 May, 2022 | US7700550 |
|
Maintenance Fee Reminder Mailed
Critical
| 06 Dec, 2021 | US7700550 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Apr, 2021 | US7608282 (Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Sep, 2020 | US7544364 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Sep, 2020 | US7531623 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 04 Oct, 2019 | US8158580 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2019 | US7351691 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 11 Jul, 2019 | US8101575 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Oct, 2018 | US7208471 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Oct, 2017 | US7700550 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 07 Sep, 2017 | US7008923 |
Cumberland Drug Patents' Oppositions Filed in EPO
Cumberland drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Apr 30, 2008, by Boeters & Lieck. This opposition was filed on patent number EP04708393A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP04708393A | Apr, 2008 | Harrison Goddard Foote | Opposition rejected |
| EP04708393A | Apr, 2008 | BOETERS & LIECK | Opposition rejected |
Cumberland's Family Patents
Cumberland Drug List
Given below is the complete list of Cumberland's drugs and the patents protecting them.
1. Sancuso
Sancuso is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7608282 | Transdermal granisetron |
22 Jan, 2025
(2 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sancuso's drug page
2. Vaprisol
Vaprisol is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5723606 | Condensed benzazepine derivative and pharmaceutical composition thereof |
15 Dec, 2019
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vaprisol's drug page
3. Vaprisol In 5% Dextrose In Plastic Container
Vaprisol In 5% Dextrose In Plastic Container is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5723606 | Condensed benzazepine derivative and pharmaceutical composition thereof |
15 Dec, 2019
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vaprisol In 5% Dextrose In Plastic Container's drug page
4. Vibativ
Vibativ is protected by 11 patents, out of which 10 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7531623 | Hydrochloride salts of a glycopeptide phosphonate derivative |
01 Jan, 2027
(2 years from now)
| Active |
| US6635618 | Glycopeptide phosphonate derivatives |
11 Sep, 2023
(1 year, 2 months ago)
| Expired |
| US6858584 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
24 Aug, 2022
(2 years ago)
| Expired |
| US6872701 | Glycopeptide phosphonate derivatives |
05 Jun, 2021
(3 years ago)
| Expired |
| US7008923 | Glycopeptide phosphonate derivatives |
06 May, 2021
(3 years ago)
| Expired |
| US7208471 | Glycopeptide phosphonate derivatives |
01 May, 2021
(3 years ago)
| Expired |
| US7351691 | Glycopeptide phosphonate derivatives |
01 May, 2021
(3 years ago)
| Expired |
| US7544364 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
01 May, 2021
(3 years ago)
| Expired |
| US7700550 | Glycopeptide phosphonate derivatives |
01 May, 2021
(3 years ago)
| Expired |
| US8101575 | Glycopeptide phosphonate derivatives |
01 May, 2021
(3 years ago)
| Expired |
| US8158580 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
01 May, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vibativ's drug page